This comparison showed that signaling pathways with the highest levels of gene activation in HBL samples expressing increased p53 are typical for aggressive liver cancer with mitotic instability; while the pathways with highest gene activation in HBL samples expressing decreased p53 are involved in activation of immune processes (Fig. 3h). The gene discussed is TP53; the disease is liver cancer.